Pretax income is the income that a company earns before paying income taxes. enVVeno Medical's pretax income for the
three
months ended in Mar. 2024 was $-4.99 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-22.12 Mil.
enVVeno Medical's pretax margin was %.
During the past 9 years, enVVeno Medical's highest Pretax Margin was -710.94%. The lowest was -24596.77%. And the median was -4410.54%.
enVVeno Medical Pre-Tax Income Historical Data
The historical data trend for enVVeno Medical's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of enVVeno Medical's Pre-Tax Income
For the Medical Devices subindustry, enVVeno Medical's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
enVVeno Medical's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, enVVeno Medical's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where enVVeno Medical's Pre-Tax Income falls into.
enVVeno Medical Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
enVVeno Medical's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-22.12 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
enVVeno Medical (NAS:NVNO) Pre-Tax Income Explanation
enVVeno Medical's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as
During the past 9 years, enVVeno Medical's highest Pretax Margin was -710.94%. The lowest was -24596.77%. And the median was -4410.54%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
enVVeno Medical Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of enVVeno Medical's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
enVVeno Medical (enVVeno Medical) Business Description
enVVeno Medical Corp is a medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its lead product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NVNO has been successfully added to your 